Toshihiro Akaike

3.3k citations
87 papers · 2.7k indexed · h-index 32

Toshihiro Akaike

86 papers receiving 2.6k citations

Peers

Toshihiro Akaike
Comparison fields: 5 of 100
  • Hepatology 639
  • Biomaterials 782
  • Molecular Medicine 123
  • Pharmaceutical Science 130
  • Surfaces, Coatings and Films 139
Replace Zohreh Amoozgar with:
Zohreh Amoozgar United States
Jie Wen China
Padmavathy Rajagopalan United States
Arihiro Kano Japan
Feng Shen China
Zaki Megeed United States
Michael S. Goldberg United States
Gregory H. Underhill United States
Yajun Guo China
Fumio Fukai Japan
Toshihiro Akaike relative to Zohreh Amoozgar United States Zohreh Amoozgar's profile →
Citations per field
00.5×3.2×
Zohreh Amoozgar · 1×
Citations per year

Countries citing papers authored by Toshihiro Akaike

Since Specialization
Citations

This map shows the geographic impact of Toshihiro Akaike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiro Akaike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiro Akaike more than expected).

Fields of papers citing papers by Toshihiro Akaike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihiro Akaike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiro Akaike. The network helps show where Toshihiro Akaike may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Toshihiro Akaike, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toshihiro Akaike Line = papers co-authored together Toshihiro Akaike links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20128
2 201234
3 201137
4 201063
5 200829
6 200723
7 200610
8 200665
9 2005105
10 2005100
11 200519
12 200416
13 200450
14 200328
15 200139
16 199951
17 19986
18 199718
19 199233
20 199215

About Toshihiro Akaike

Toshihiro Akaike is a scholar working on Hepatology, Biomaterials and Pharmaceutical Science, having authored 87 papers that have together received 2.7k indexed citations. Recurring topics across this work include Liver physiology and pathology (35 papers), RNA Interference and Gene Delivery (22 papers), Pancreatic function and diabetes (21 papers), 3D Printing in Biomedical Research (17 papers), Tissue Engineering and Regenerative Medicine (15 papers), Pluripotent Stem Cells Research (11 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Biopolymer Synthesis and Applications (8 papers). The work is most often cited by research in Hepatology (639 citations), Biomaterials (782 citations) and Molecular Medicine (123 citations). Toshihiro Akaike has collaborated with scholars based in Japan, South Korea and United States. Frequent co-authors include Kazukiyo Kobayashi, Hirohiko Ise, Yoshifumi Watanabe, Chong‐Su Cho, Masato Nagaoka, Ezharul Hoque Chowdhury, Atsushi Maruyama, Mitsuaki Goto, Akira Kobayashi and Takashi Hoshiba. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026